Baba, D.-F.; Danilesco, A.; Suciu, H.; Avram, C.; Harpa, M.M.; Stoian, M.; Moldovan, D.-A.; Huma, L.; Rusu, G.; Pal, T.;
et al. The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients. Biomedicines 2025, 13, 1164.
https://doi.org/10.3390/biomedicines13051164
AMA Style
Baba D-F, Danilesco A, Suciu H, Avram C, Harpa MM, Stoian M, Moldovan D-A, Huma L, Rusu G, Pal T,
et al. The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients. Biomedicines. 2025; 13(5):1164.
https://doi.org/10.3390/biomedicines13051164
Chicago/Turabian Style
Baba, Dragos-Florin, Alina Danilesco, Horatiu Suciu, Calin Avram, Marius Mihai Harpa, Mircea Stoian, Diana-Andreea Moldovan, Laurentiu Huma, Gabriel Rusu, Tunde Pal,
and et al. 2025. "The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients" Biomedicines 13, no. 5: 1164.
https://doi.org/10.3390/biomedicines13051164
APA Style
Baba, D.-F., Danilesco, A., Suciu, H., Avram, C., Harpa, M. M., Stoian, M., Moldovan, D.-A., Huma, L., Rusu, G., Pal, T., Stoian, A., & Sin, A.-I.
(2025). The Effect of Early Spironolactone Administration on 2-Year Acute Graft Rejection in Cardiac Transplant Patients. Biomedicines, 13(5), 1164.
https://doi.org/10.3390/biomedicines13051164
